Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Phase 2a Study to Evaluate the Safety and Tolerability of GM-2505 in Patients With MDD

Gilgamesh Pharmaceuticals · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
major-depressive-disorder
major depressive disorder, mdd, adjunctive, antidepressant, 5ht2a agonist, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1046282
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.